News
TopoTarget gewinnt erfolgreich vollständige Kontrolle über Belinostat...
www.ots.at
- Konsolidierung der weltweiten Produktrechte
Oncology Venture A/S: Oncology Venture enters into financing agreement
www.finanznachrichten.de
Company AnnouncementOncology Venture A/S enters into a financing agreement based on the issuance of convertible notes and warrants Hoersholm, Denmark, November...
Oncology Ventures CEO Peter Buhl Jensen buys shares in the
www.globenewswire.com
Company Announcement Oncology Ventures CEO Peter Buhl Jensen buys shares in the Company Hoersholm, Denmark – December 6, – Oncology Venture A/S...
A match made in Scandinavia - European Biotechnology
european-biotechnology.com
„When I entered the company in as a CEO it seemed to me like a rational model to use MPI's drug response predictor (DRP) technology for developing a propriertary cancer drug pipeline and benefit from the full value the DRP can add a drug,” Peter Buhl Jensen told EuroBiotech. The result was a spin-off dubbed Oncology Venture.
sortiert nach Relevanz / Datum